297 related articles for article (PubMed ID: 29311086)
1. Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon.
Groger M; Veletzky L; Lalremruata A; Cattaneo C; Mischlinger J; Zoleko-Manego R; Endamne L; Klicpera A; Kim J; Nguyen T; Flohr L; Remppis J; Matsiegui PB; Adegnika AA; Agnandji ST; Kremsner PG; Mordmüller B; Mombo-Ngoma G; Ramharter M
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311086
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon.
Mombo-Ngoma G; Kleine C; Basra A; Würbel H; Diop DA; Capan M; Adegnika AA; Kurth F; Mordmüller B; Joanny F; Kremsner PG; Ramharter M; Bélard S
Malar J; 2012 Jul; 11():120. PubMed ID: 22515681
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
Siswantoro H; Russell B; Ratcliff A; Prasetyorini B; Chalfein F; Marfurt J; Kenangalem E; Wuwung M; Piera KA; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Antimicrob Agents Chemother; 2011 Jan; 55(1):197-202. PubMed ID: 20937779
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial.
Groger M; Tona Lutete G; Mombo-Ngoma G; Ntamabyaliro NY; Kahunu Mesia G; Muena Mujobu TB; Dimessa Mbadinga LB; Zoleko Manego R; Egger-Adam D; Borghini-Fuhrer I; Shin J; Miller R; Arbe-Barnes S; Duparc S; Ramharter M
Lancet Microbe; 2022 Aug; 3(8):e598-e605. PubMed ID: 35654079
[TBL] [Abstract][Full Text] [Related]
6. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
[TBL] [Abstract][Full Text] [Related]
7. Evidence of non-Plasmodium falciparum malaria infection in Kédougou, Sénégal.
Daniels RF; Deme AB; Gomis JF; Dieye B; Durfee K; Thwing JI; Fall FB; Ba M; Ndiop M; Badiane AS; Ndiaye YD; Wirth DF; Volkman SK; Ndiaye D
Malar J; 2017 Jan; 16(1):9. PubMed ID: 28049489
[TBL] [Abstract][Full Text] [Related]
8. Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing.
Lalremruata A; Jeyaraj S; Engleitner T; Joanny F; Lang A; Bélard S; Mombo-Ngoma G; Ramharter M; Kremsner PG; Mordmüller B; Held J
Malar J; 2017 Oct; 16(1):398. PubMed ID: 28974215
[TBL] [Abstract][Full Text] [Related]
9. Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.
Betson M; Sousa-Figueiredo JC; Atuhaire A; Arinaitwe M; Adriko M; Mwesigwa G; Nabonge J; Kabatereine NB; Sutherland CJ; Stothard JR
Parasitology; 2014 Dec; 141(14):1880-90. PubMed ID: 24837880
[TBL] [Abstract][Full Text] [Related]
10. Limited Polymorphism of the Kelch Propeller Domain in Plasmodium malariae and P. ovale Isolates from Thailand.
Nakeesathit S; Saralamba N; Pukrittayakamee S; Dondorp A; Nosten F; White NJ; Imwong M
Antimicrob Agents Chemother; 2016 Jul; 60(7):4055-62. PubMed ID: 27114275
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine.
Tournoy TK; Rosanas-Urgell A; Van Esbroeck M; Bottieau E; Huits R
Int J Infect Dis; 2022 Jun; 119():56-58. PubMed ID: 35358721
[TBL] [Abstract][Full Text] [Related]
12. A Phase II Pilot Trial to Evaluate
Noudjiegbe AN; Alikekere FN; Tchehouenou H; Langa Y; Ota DS; Degbelo JE; Allabi ACE
Evid Based Complement Alternat Med; 2020; 2020():8715021. PubMed ID: 32215047
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia.
Abamecha A; Yilma D; Addisu W; El-Abid H; Ibenthal A; Noedl H; Yewhalaw D; Moumni M; Abdissa A
Malar J; 2020 Jul; 19(1):240. PubMed ID: 32650784
[TBL] [Abstract][Full Text] [Related]
14. Genome-scale comparison of expanded gene families in Plasmodium ovale wallikeri and Plasmodium ovale curtisi with Plasmodium malariae and with other Plasmodium species.
Ansari HR; Templeton TJ; Subudhi AK; Ramaprasad A; Tang J; Lu F; Naeem R; Hashish Y; Oguike MC; Benavente ED; Clark TG; Sutherland CJ; Barnwell JW; Culleton R; Cao J; Pain A
Int J Parasitol; 2016 Oct; 46(11):685-96. PubMed ID: 27392654
[TBL] [Abstract][Full Text] [Related]
15. Persistent transmission of Plasmodium malariae and Plasmodium ovale species in an area of declining Plasmodium falciparum transmission in eastern Tanzania.
Yman V; Wandell G; Mutemi DD; Miglar A; Asghar M; Hammar U; Karlsson M; Lind I; Nordfjell C; Rooth I; Ngasala B; Homann MV; Färnert A
PLoS Negl Trop Dis; 2019 May; 13(5):e0007414. PubMed ID: 31136585
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium ovale curtisi and Plasmodium ovale wallikeri in North-West Ethiopia.
Alemu A; Fuehrer HP; Getnet G; Tessema B; Noedl H
Malar J; 2013 Sep; 12():346. PubMed ID: 24073668
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of Plasmodium malariae and Plasmodium ovale mono-infections among children in the Democratic Republic of the Congo: a population-based, cross-sectional study.
Doctor SM; Liu Y; Anderson OG; Whitesell AN; Mwandagalirwa MK; Muwonga J; Keeler C; Emch M; Likwela JL; Tshefu A; Meshnick SR
Malar J; 2016 Jul; 15():350. PubMed ID: 27392905
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
Onyamboko MA; Hoglund RM; Lee SJ; Kabedi C; Kayembe D; Badjanga BB; Turner GDH; Jackson NV; Tarning J; McGready R; Nosten F; White NJ; Day NPJ; Fanello C
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818818
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study.
Akala HM; Watson OJ; Mitei KK; Juma DW; Verity R; Ingasia LA; Opot BH; Okoth RO; Chemwor GC; Juma JA; Mwakio EW; Brazeau N; Cheruiyot AC; Yeda RA; Maraka MN; Okello CO; Kateete DP; Managbanag JR; Andagalu B; Ogutu BR; Kamau E
Lancet Microbe; 2021 Apr; 2(4):e141-e150. PubMed ID: 35544189
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia.
Getnet G; Fola AA; Alemu A; Getie S; Fuehrer HP; Noedl H
Malar J; 2015 Jun; 14():258. PubMed ID: 26105035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
